Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
POLICY PAPERS
August 07, 2023
A main driver of antimicrobial resistance is the misuse and overuse of antimicrobials. But lack of access to antimicrobials causes a large mortality burden and contributes to the spread of resistant infections. How can learnings from the use of control policies in other areas of medicine be translat...
POLICY PAPERS
June 20, 2023
This policy paper examines the state of knowledge on investing in the “best buys” of surveillance for pandemic preparedness. We conduct a rapid literature review to assess the state of knowledge on the costs and benefits of investing in four selected types of surveillance for respiratory infections,...
POLICY PAPERS
November 28, 2022
The experience of the COVID-19 pandemic—in the US and around the world—highlights the potential feasibility and importance of biomedical R&D for global health and welfare. Drawing from this experience and momentum, this paper argues that the US should deepen its engagement and ambition in global hea...
POLICY PAPERS
November 23, 2022
Pull financing is an underutilized tool that can drive the development and adoption of critical technologies necessary to address the globe’s climate crisis. This paper provides tangible examples by presenting two case studies that illustrate how pull climate finance can be used to deliver urgently ...
POLICY PAPERS
November 15, 2022
Antimicrobial drugs form the backbone of modern medicine. Yet over time, use of these drugs selects for mutations that survive exposure to those same drugs, driving “antimicrobial resistance,” or AMR. In the absence of sufficient R&D investment for new antimicrobials, deaths from drug-resistant infe...
POLICY PAPERS
November 03, 2022
Pull financing is a powerful but underused mechanism for incentivising progress on hard-to-tackle social problems for which innovation or the take-up of innovation may be part of the solution. It should become part of the ongoing landscape for climate and development work. This paper sets out the sp...
POLICY PAPERS
October 04, 2022
In this paper, we report the results of a horizon-scanning exercise to source opportunities for global health R&D investment—that is, high-value potential biomedical innovations which are currently underfunded but which could be transformative for health, quality of life, and health security in LMIC...
POLICY PAPERS
November 10, 2021
An increasing share of official development assistance is being used for climate-related activities. This trend is continuing despite the lack of comprehensive cost-effectiveness evidence to guide spending decisions and continuing concerns that few applications are effective or efficient mechanisms ...
POLICY PAPERS
October 25, 2021
In an updated review of how the COVID-19 pandemic has been affecting women’s and girls’ health in low- and middle-income contexts, we examine 247 studies between January and March 2021 (peer-reviewed papers, pre-prints, and working papers that met specific search terms, and contained empirical analy...
POLICY PAPERS
August 11, 2021
To help the US government make broader use of pull approaches, this policy paper surveys the ways in which US government authorities, budgetary rules, and procurement approaches either facilitate or constrain use of pull mechanisms to support R&D. It specifically focused on the budgetary “scorin...